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Regulated exocytosis of synaptic vesicles is substantially faster than of endocrine dense core
vesicles despite similar molecular machineries. The reasons for this difference are unknown
and could be due to different regulatory proteins, different spatial arrangements, different
vesicle sizes, or other factors. To address these questions, we take a reconstitution approach
and compare regulated SNARE-mediated fusion of puriﬁed synaptic and dense core chro-
mafﬁn and insulin vesicles using a single vesicle-supported membrane fusion assay. In all
cases, Munc18 and complexin are required to restrict fusion in the absence of calcium.
Calcium triggers fusion of all docked vesicles. Munc13 (C1C2MUN domain) is required for
synaptic and enhanced insulin vesicle fusion, but not for chromafﬁn vesicles, correlating
inversely with the presence of CAPS protein on puriﬁed vesicles. Striking disparities in cal-
cium-triggered fusion rates are observed, increasing with curvature with time constants
0.23 s (synaptic vesicles), 3.3 s (chromafﬁn vesicles), and 9.1 s (insulin vesicles) and corre-
lating with rate differences in cells.
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It is well established that calcium-triggered exocytosis ofsynaptic vesicles is signiﬁcantly faster than that of large dense-core vesicles in neurons and neuroendocrine cells despite
identical SNARE proteins and similar regulatory proteins. These
differences are thought to be caused by variations in spatial
organization (e.g., with respect to calcium channels), vesicle size,
or the precise molecular composition of the release sites, but how
exactly these factors determine release kinetics is not known. It is
also well known that the ﬁnal exocytotic step of membrane fusion
is catalyzed by speciﬁc SNARE proteins including syntaxin-1a
and SNAP-25 in the plasma membrane and synaptobrevin-2/
VAMP-2 in the secretory vesicle membrane, and that these
essential SNARE proteins form the core fusion machinery in
neuronal synaptic vesicles, in adrenal chromafﬁn dense-core
vesicles, and in endocrine pancreatic insulin vesicles (also referred
to as insulin granules). Moreover, the regulatory proteins
Munc18, complexin, synaptotagmin, and a MUN domain-
containing protein, such as Munc13 or CAPS (calcium acti-
vated protein for secretion) are required in all three cell types to
regulate assembly, prevent fusion in the absence of calcium, and
prime the SNAREs for rapid fusion in response to elevated levels
of calcium1. Finally, speciﬁc isoforms of the secretory vesicle
protein synaptotagmin function as the calcium sensors that
trigger the fusion reaction in all three systems2. The fact that the
protein compositions are so similar in these physiologically very
distinct cell types raises the question whether the kinetic differ-
ences are an intrinsic property of the release machinery or
whether they are caused by more complex cellular factors such as
the spatio-temporal properties of the calcium trigger. A recently
developed reconstitution system that allows studying docking,
priming, and fusion kinetics of vesicles from natural sources in a
single-vesicle assay3 was used to mechanistically investigate
kinetic differences of different secretory vesicle types. This assay is
ideally suited to answer key questions about the source of the
different kinetics and details of the regulation of the docking,
priming, and fusion processes by key proteins such as Munc18,
complexin, Munc13, synaptotagmin, and CAPS.
Complete biochemical reconstitution approaches starting from
all puriﬁed components have been powerful to dissect many
elements of the mechanisms these proteins utilize to drive
fusion4–8. SNARE-mediated fusion of secretory vesicles puriﬁed
from endogenous sources has also been reconstituted into fusion
assays with artiﬁcial membranes, but most of these fusion assays
do not distinguish between docking, priming, and fusion9–14.
Recently, it was shown that recombinant Munc18 and complexin-
1 can be added during reconstitution of dense-core vesicles
puriﬁed from PC12 cells to generate a docked state that does not
proceed to fusion until calcium is injected3,15. However, whether
other secretory vesicles from different cell types can be arrested in
this state and triggered for fusion in a similar manner is still
unclear.
To build on this capability and to determine mechanistic dif-
ferences among secretory vesicle types, the secretory vesicle—
reconstituted planar membrane fusion approach was extended to
synaptic vesicles and insulin granules. Similar to dense-core
vesicles from PC12 cells3, insulin vesicles can be labeled bio-
synthetically through the expression of ﬂuorescently tagged
proinsulin, which is processed and packaged among the vesicle
content16. Because synaptic vesicles do not have a secretory
protein content, a different strategy was used to achieve internal
ﬂuorescent labeling. Capitalizing on the presence of the endo-
genous proton pump17, ATP-driven internal acidiﬁcation enabled
concentration of the ﬂuorescent weak base acridine orange within
synaptic vesicles. For comparison, this same approach was also
employed with puriﬁed dense-core vesicles and insulin vesicles
enabling simultaneous monitoring of fusion with a ﬂuorescently
tagged protein and a small ﬂuorescent reporter. All three vesicle
types interact with planar bilayers in a SNARE dependent man-
ner. Addition of Munc18 and complexin-1 to the planar-
supported membrane fusion assay arrests all three secretory
vesicles in a docked non-fusing state. In the presence of a MUN
domain-containing protein, calcium readily triggers fusion of the
vesicles from this docked/primed state. In the case of synaptic
vesicles, this was achieved by addition of a recombinant
C1C2MUN region of Munc13. The puriﬁed dense-core vesicles
did not have the strict requirement for this recombinant Munc13
construct because of the presence of the endogenous MUN
domain-containing proteins CAPS-1 and CAPS-2 present on the
vesicle. Insulin vesicle samples contained a small fraction of the
total cellular CAPS-2, however they showed an additional kinetic
enhancement of calcium-stimulated fusion upon addition of the
C1C2MUN fragment. Despite using a similar well controlled
docking and priming machinery in the target membrane, each
vesicle type has distinct fusion kinetics that directly correlates
with its curvature and is independent of synaptotagmin isoform
and vesicle SNARE density in the vesicle membrane.
Results
Secretory vesicle labeling and single-vesicle fusion. Dense-core
vesicles and insulin vesicles were puriﬁed from PC12 and
INS1 cells, respectively, using an iso-osmotic fractionation pro-
cedure (see Methods, Supplementary Fig. 1b, d, e). The lumen of
the dense-core vesicles was ﬂuorescently labeled by expressing
neuropeptide-Y tagged to mRuby (NPY-mRuby)3. The insulin
vesicles were puriﬁed from INS1 cells that stably express human
proinsulin containing a green ﬂuorescent protein insert in the C-
peptide domain (C-peptide-GFP). The expressed proinsulin
derivative is transported and processed similarly to endogenous
proinsulin, and C-peptide-GFP is stored and secreted in parallel
with endogenous insulin providing a ﬂuorescent label of the
insulin vesicle content16. When puriﬁed and examined for fusion
with reconstituted planar membranes containing the plasma
membrane SNARE proteins by TIRF microscopy, both single
dense-core vesicle and single insulin vesicle fusion events can be
analyzed by observing similar characteristic ﬂuorescent signals
that have been described in detail previously for dense-core
vesicles (Fig. 1a, b)3,18. In these experiments, asymmetric-
supported membranes were prepared containing lipids mimick-
ing the plasma membrane (brain(b)PC:bPE:bPS:chol:PI:bPIP2 at
the ratio 25:25:15:30:4:1 on the cytoplasmic mimicking leaﬂet and
67:30:3 bPC:chol:DMPE-PEG2000-triethoxysilane (DPS) on the
extracellular mimicking leaﬂet) and a minimal target membrane
SNARE fusion machinery consisting of syntaxin-1a (183–288
lacking the regulatory Habc domain) and dodecylated SNAP-25
(dSNAP-25)19. Upon addition of dense-core vesicles or insulin
vesicles to the planar-supported membranes, the peak ﬂuores-
cence intensity originating from single secretory vesicles increases
when the vesicle enters the TIRF ﬁeld and binds to the planar
membrane, decreases transiently at the onset of fusion, then
increases rapidly as the vesicle collapses into the planar mem-
brane, and ﬁnally decreases toward baseline as the label diffuses
away from the site of fusion (Fig. 1a, b, g and Supplementary Fig.
2) as previously demonstrated3,18.
Synaptic vesicles have been puriﬁed from rat brain and
characterized in detail17, and their SNARE-mediated membrane
fusion to planar-supported membranes containing the plasma
membrane SNAREs has been monitored previously using
ﬂuorescent lipids as indicators10. The fractionation scheme and
western blots of fractions used to obtain puriﬁed synaptic vesicles
are shown in Supplementary Fig. 1a, c for comparison with the
other secretory vesicle puriﬁcations. The interior of the synaptic
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11873-8
2 NATURE COMMUNICATIONS |         (2019) 10:3904 | https://doi.org/10.1038/s41467-019-11873-8 | www.nature.com/naturecommunications
vesicles was loaded with the ﬂuorescent marker acridine orange
for fusion studies. This was done by generating a transmembrane
proton gradient by means of the V-ATPase proton pump on the
synaptic vesicle17. In the presence of ATP and the K+-ionophore
valinomycin, acridine orange concentrates into the synaptic
vesicle interior in response to vesicle lumen acidiﬁcation, which
can be observed by the progressive self-quenching of the acridine
orange ﬂuorescence (Fig. 2a)20. The addition of the proton pump
inhibitor baﬁlomycin A blocks acridine orange loading, whereas
the protonophore CCCP rapidly reverses dye loading (Fig. 2a).
Acridine orange loading was optimized for the TIRF planar-
supported membrane fusion assay by increasing concentrations
of secretory vesicles (relative to the loading experiments) and
decreasing the concentration of acridine orange to 0.1 μMmaking
the dye amenable for optimal visualization in the planar-
supported membrane fusion assay.
A representative ﬂuorescent signal from an acridine orange-
loaded synaptic vesicle docking and fusing with a plasma
membrane mimicking planar-supported bilayer-containing
syntaxin-1a (183–288) and dSNAP-25 is shown in Fig. 1c and
more examples are shown in Supplementary Fig. 2a. The abrupt
increase in ﬂuorescence at the time indicated as 0 identiﬁes
synaptic vesicle docking to the planar-supported membrane. The
following increase in ﬂuorescence after ~250 ms indicates the
onset of fusion as the acridine orange dye moves close to the
evanescent TIRF ﬁeld and dequenches. The ﬂuorescence intensity
ﬁrst peaks and then decreases as the dye diffuses away from the
site of fusion inside the cleft between supported membrane and
quartz substrate (Fig. 1c, g and Supplementary Fig. 2a).
Double labeling of dense-core vesicles and insulin vesicles
allowed for a direct comparison of release signals originating
from different ﬂuorescent reporters. Both dense-core vesicles and
insulin vesicles have functional V-ATPase proton pumps, thus
can concentrate acridine orange in the presence of ATP and
valinomycin. Acidiﬁcation is reversible by CCCP and inhibited in
the presence of baﬁlomycin (Fig. 2b, c). A fusion event of a dense-
core vesicle simultaneously labeled with acridine orange and
NPY-mRuby is shown in Fig. 1d. The acridine orange fusion peak
begins about 200 ms prior to the initial dip observed with the
NPY-mRuby signal. Thus, the initial narrow fusion pore allows
the release of small molecules like acridine orange while still
blocking the diffusion of the bulkier NPY-mRuby through the
pore. After ~200 ms from the onset of the acridine orange peak,
the NPY-mRuby signal begins to decrease indicating the pore has
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Fig. 1 Characteristic fusion events of puriﬁed secretory vesicles with planar-
supported membranes. The intensity traces of the peak intensity pixel of a
single secretory vesicle docking and fusing with the planar-supported
bilayer containing t-SNAREs are shown for a dense-core vesicles labeled
with NPY-mRuby, b insulin vesicles labeled with C-peptide-GFP, and c
synaptic vesicles labeled with acridine orange. The single events are
representative examples with more example events shown in
Supplementary Fig. 2. d Intensity traces from a double-labeled (acridine
orange, red; NPY-Ruby, black) dense-core vesicle illustrates that during
fusion, egress of acridine orange precedes NPY-Ruby by ~200ms. Intensity
traces from insulin vesicles double-labeled with e C-peptide-GFP and NPY-
mRuby or with f NPY-mRuby and acridine orange show that C-peptide-GFP
and NPY-mRuby have the same characteristic release behavior while
acridine orange starts to be released about ~200ms before the onset of
release of the ﬂuorescent proteins. g Schematic drawing of the theoretical
intensity traces for single secretory vesicles labeled with a ﬂuorescent
protein (black) or acridine orange (red). Intensity traces are of a region of
interest over time. I. Initially the labeled secretory vesicle is not within the
TIRF ﬁeld and no ﬂuorescence is observed. II. The vesicle docks to the
planar-supported membrane causing an immediate increase of
ﬂuorescence intensity in the TIRF ﬁeld. III. After some time, the vesicle
fuses with the planar membrane. The onset of fusion begins with the
opening of a small fusion pore resulting in an increase in ﬂuorescence of the
small molecule dye acridine orange or a decrease in ﬂuorescence of the
ﬂuorescent protein. The decrease in observed ﬂuorescence is due to lateral
diffusion of the ﬂuorescent indicator away from the site of fusion. When
fusion is observed with a ﬂuorescent protein, the protein is ﬁrst more slowly
released through the initial narrow fusion pore until, at time point IV, the
vesicle collapses into the planar membrane as observed by an increase in
ﬂuorescence due to the forward movement of the protein within the TIRF
ﬁeld following a continued decrease in intensity as the protein continues to
leave the fusion site
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fusion. Approximately 600 ms after the onset of NPY-mRuby
diffusion the dense-core vesicle collapses into the planar-
supported membrane pulling the remaining NPY-mRuby for-
ward into the TIRF ﬁeld, which generates the peak ﬂuorescence
prior to the ﬁnal decay of ﬂuorescence due to diffusion away from
the site of fusion (see Supplementary Fig. 1 of ref. 3 for further
explanation of single-vesicle fusion kinetic line shapes). The
overlap of the spectra of GFP and acridine orange prevents their
simultaneous imaging. Previously, NPY was shown to concen-
trate in the same compartment as C-peptide-GFP when expressed
in INS1 cells21. Puriﬁcation of insulin granules from cells
expressing NPY-mRuby and C-peptide-GFP together showed
that these ﬂuorescent markers are released at the same time in the
planar-supported membrane fusion assay (Fig. 1e). Labeling
insulin vesicles that only expressed NPY-mRuby with acridine
orange revealed similar results to those obtained with dense-core
vesicles, namely that the acridine orange signal preceded the
decrease in NPY-mRuby signal by ~200 ms (Fig. 1f).
Munc13 dependence of calcium-triggered native vesicle fusion.
The ﬂuorescently tagged proteins in dense-core vesicles and
insulin vesicles, and the acridine orange dye in synaptic vesicles
were used to quantify docking and fusion in the supported
membrane fusion assay. Docking of synaptic vesicles, dense-core
vesicles, and insulin vesicles depends on syntaxin-1a and SNAP-
25 (Fig. 3a and Supplementary Table 1). Docking is abolished if
either or both of these plasma membrane SNAREs are omitted or
in the presence of an inhibitor peptide comprising the soluble
domain of synaptobrevin-2 (residues 1–96). As compared to
truncated syntaxin-1a (residues 183–288), full-length syntaxin-1a
(residues 1–288) containing the regulatory Habc domain,
decreases the number of docking events, but fusion is still
observed. Incubating Munc18 and complexin-1 with the recon-
stituted plasma membrane SNAREs syntaxin-1a(1-288) and
dSNAP-25 allows vesicles to dock while inhibiting fusion in the
absence of calcium (Fig. 3a and Supplementary Table 1). The
addition of 100 μM calcium to these docked vesicles stimulates
fusion with the planar-supported membranes (Fig. 3b, Supple-
mentary Fig. 3, and Supplementary Table 2). The inclusion of a
ﬂuorescent dye in the calcium-containing buffer allowed the delay
times between calcium arrival and fusion to be measured (Fig. 3b
and Supplementary Fig. 4). The measured time from the com-
mencement of calcium buffer arrival to saturation of the buffer
(ΔtCa) was determined for each experiment measured (Supple-
mentary Fig. 4, Supplementary Tables 2 and 3). All conditions
had a ΔtCa of <0.5 s.
The calcium-stimulated fusion dependence on Munc13 was
tested by inclusion of the C1C2MUN domain in the buffer
containing the secretory vesicles when they are injected to dock
on planar-supported bilayers containing the plasma membrane
SNARE complex (syntaxin-1a[1-288] and dSNAP-25), Munc18,
and complexin-1 (Fig. 4a–e). As a consequence, the efﬁciency,
and kinetics of calcium-triggered fusion for synaptic vesicles
increased markedly upon the addition of C1C2MUN (Fig. 4a, e).
Although C1C2MUN addition had very little effect on dense-core
vesicle fusion (Fig. 4b, e), there was a signiﬁcant kinetic effect on
insulin vesicle fusion as well as a slightly increased fusion
probability (Fig. 4c, e). These effects can be rationalized by the
level of CAPS-1/2 in the different puriﬁed secretory vesicle
preparations. Dense-core vesicle fractions contain readily detect-
able amounts of both isoforms of CAPS (Supplementary Fig. 1),
insulin vesicles contain a small fraction of the total cellular CAPS-
2 isoform (Supplementary Fig. 1), whereas the puriﬁed synaptic
vesicle samples do not contain any CAPS (Supplementary Fig. 1
and 18). The delay in the kinetics of insulin vesicles indicates an
incomplete priming that is overcome by the presence of
C1C2MUN changing the kinetics to a ﬁrst order reaction
(Fig. 4c). The sigmoidal shape of the kinetic curve in the absence
of added C1C2MUN to insulin vesicles indicates hidden priming
steps that may be delayed due to suboptimal amounts of CAPS-2
or the lack of CAPS-1 in our preparations. The requirement of
the Munc13 C1C2MUN domain for priming in the absence of
CAPS in dense-core vesicles is consistent with a previous
observation that the efﬁciencies and rates of calcium-stimulated
fusion of dense-core vesicles puriﬁed from CAPS-1/2 knockdown
cell lines decreased dramatically, but could be restored by the
addition of the C1C2MUN domain of Munc13 (Fig. 4d) (see also
ref. 3).
Fusion kinetics of secretory vesicles correlate with size. Com-
paring the fusion kinetics from the time of calcium arrival for the
three secretory vesicle types, in the presence of Munc18, com-
plexin-1, and C1C2MUN revealed striking differences in the rate
of fusion. The cumulative distributions of measured delay times
were well described by a ﬁt with a single rate constant for each













































































Fig. 2 Puriﬁed secretory vesicles contain functional V-ATPase acidiﬁcation of a synaptic vesicles, b dense-core vesicles, or c insulin vesicles. Bulk acridine
orange ﬂuorescence was monitored in the presence of the secretory vesicle and valinomycin (black line). Addition of ATP drives progressive self-
quenching of the acridine orange ﬂuorescence due to concentration into the interior of the secretory vesicle. The addition of CCCP dissipates the pH
gradient causing an increase in acridine orange ﬂuorescence. The presence of baﬁlomycin inhibits the proton pump preventing the acidiﬁcation of the
secretory vesicles (blue traces)
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with a characteristic time constant of 0.23 s, whereas dense-core
vesicle and insulin vesicle fusion proceeded more slowly with
time constants of 3.3 and 9.1 s, respectively, from the time of
calcium arrival (Fig. 5a). Determining the kinetics for the fusion
reaction after calcium arrival for insulin vesicles labeled with C-
peptide-GFP, NPY-mRuby, or acridine orange revealed that the
observed delay times are independent of the labeling strategy
(Supplementary Fig. 5, Supplementary Table 3).
All three secretory vesicles were reconstituted into the same
lipid- and protein-environment in the planar-supported target
membranes, indicating that the observed differences in fusion
kinetics are caused by the secretory vesicle. The different
secretory vesicles contain different isoforms of the calcium
sensor for exocytosis, synaptotagmin, namely synaptotagmin-1,
-7, and -9. Single isoforms of synaptotagmin were expressed into
a previously characterized PC12 cell line lacking endogenous
secretory vesicle synaptotagmins. Purifying the secretory vesicles
and determining the fusion kinetics from the time of calcium
arrival revealed that synaptotagmin-7-containing dense-core
vesicles have a slightly faster rate constant than synaptotagmin-
1 and synaptotagmin-9 dense-core vesicles (Fig. 5b, Supplemen-
tary Fig. 6, and Supplementary Table 4), in agreement with
similar data obtained in intact cells22. Therefore, the differences
in rates caused by different synaptotagmin isoforms cannot
explain the observed drastic rate differences between synaptic
vesicles, dense-core vesicles, and insulin vesicles.
Another possible explanation for the kinetic difference between
the secretory vesicle types might be variations in density of the
vesicle SNARE, VAMP-2, on the respective vesicles. It is well
known that synaptic vesicles have a high density of VAMP-2, i.e.,
~70 copies per vesicle18, but little is known about the density on
other secretory vesicle types. Previously, the VAMP-2 density was
shown to have no effect on fusion rates in a reconstituted
proteoliposome fusion assay unless the protein density was below
the threshold number required for fusion, i.e., below ~3 copies
per 40–50 nm vesicle23. To address this concern with respect to
the different secretory vesicle types, a soluble plasma membrane
Q-SNARE complex (1:1 syntaxin-1a residues 191–253 and
SNAP-25, ref. 24) was used as a competitive inhibitor to block
endogenous secretory vesicle VAMP proteins. Addition of this
soluble Q-SNARE complex decreased the density of active VAMP
on the vesicles and reduced docking of all three types of secretory
vesicles to the supported membranes in a dose-dependent
manner (Fig. 5c and Supplementary Table 5). When the three
types of secretory vesicles were docked in the presence of 0.5 μM
soluble Q-SNARE complex, i.e., a concentration that reduced
docking by roughly 50%, all three secretory vesicles types were
still competent to fuse with the planar membranes when calcium
was injected and no effect on the rate of fusion was observed for
any of the three secretory vesicle types (Fig. 5d, Supplementary
Table 6). Therefore, the VAMP density on the respective vesicles
at their respective native densities does not limit fusion as
expected from the previous reconstituted proteoliposome fusion
studies23.
The calcium-stimulated, SNARE-mediated fusion rate con-
stants range from ~4.4 s−1 for synaptic vesicles to ~0.1 s−1 for
insulin vesicles (Fig. 5a). So far, we have shown that neither the
different synaptotagmin isoforms nor VAMP density can explain
these different fusion kinetics. Another obvious difference
between these different types of secretory vesicles is their
respective size and, therefore, their respective membrane
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Fig. 3 Secretory vesicle docking and calcium-triggered fusion. a Docking of synaptic vesicles (green), dense-core vesicles (red), and insulin vesicles (blue
depends on the presence of both target SNARE proteins syntaxin-1a and SNAP-25 in the planar-supported membrane in the absence of calcium (100 µM
EDTA)). Syntaxin-1a (183–288) denotes a construct containing the transmembrane domain and the SNARE motif, whereas syntaxin-1a(1-288) is the full-
length protein that also contains the regulatory Habc domain. Secretory vesicle docking to planar-supported lipid bilayers containing different combinations
of syntaxin-1a1-288, dSNAP-25, complexin-1, and Munc18. A summary of the statistics is shown in Supplementary Table 1. b Single-vesicle fusion events
triggered by calcium from a docked state in the presence of syntaxin-1a1-288, dSNAP-25, complexin-1, Munc18, and the C1C2MUN domain of Munc13.
Single events for synaptic vesicles, dense-core vesicles, and insulin vesicles are shown. Soluble Alexa647 was included in the buffer containing 100 μM
calcium to measure calcium arrival (black trace) to determine delay times of fusion. Orange line is the precise time determined for calcium arrival. The
traces represent the release of respective ﬂuorescent content markers of acridine orange for synaptic vesicles (green), NPY-mRuby for dense-core vesicles
(red), and C-peptide-GFP (blue) for insulin vesicles. Graphs with expanded times scales around the arrival time of the calcium buffer are shown in
Supplementary Fig. 4 and more representative traces are shown in Supplementary Fig. 3. Error bars represent standard errors of the mean
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intermediates, Malinin and Lentz25, revealed that the dependence
between the energy barriers of the rate limiting step and the
curvature of fusing liposomes is roughly linear. Indeed,
when comparing the rate constants of fusion (k) with the
curvature (1/R) of the different secretory vesicles as measured by
cryo-electron microscopy (Fig. 5e), this correlation was found to
be also valid for the much more complex biological membranes
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Fig. 4Munc13 dependence of secretory vesicle kinetics. Cumulative distribution functions for synaptic vesicles (a), dense-core vesicles (b), insulin vesicles
(c), dense-core vesicles lacking endogenous CAPS-1/2 (previously described in ref. 3) (d). All kinetics are triggered from a docked state in the presence of
syntaxin-1a:dSNAP-25, Munc18, complexin-1 without (black), or with (purple) 0.2 μM of the C1C2MUN domain fragment of Munc13. Summary statistics
for each condition are shown in Supplementary Table 2. e Bar graph for the total amount of fusion in the presence of 100 µM EDTA, 100 µM calcium, or
100 µM calcium in the presence of 0.2 µM C1C2MUN domain of Munc13 for each condition. Error bars represent standard errors of the mean
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Discussion
The application of the hybrid in vitro assay for calcium-
stimulated SNARE-mediated fusion originally developed for
dense-core vesicles has been expanded here to synaptic vesicles
and insulin granules. The fusion of all three secretory vesicle types
has been established to use a similar machinery including the
exocytotic SNAREs, syntaxin-1a, and SNARE-25, in conjunction
with their regulatory proteins Munc18, complexin-1, Munc13,
and/or CAPS1,2,17,26. It is important to note that the role of the
different SNARE isoforms for insulin exocytosis is debated27, but
several groups have directly implicated syntaxin-1a and SNAP-25
in insulin secretion26,28,29. Our data indicate that Munc18 and
complexin-1 are sufﬁcient to restrict fusion of all three types of
native secretory vesicles with plasma membrane mimicking
reconstituted SNARE membranes in the absence of calcium. This
behavior is expected based on genetic screens with physiological
read-outs in cells, but is often not as robust in fully reconstituted
systems as it is in the system employed here. Injection of phy-
siological concentrations of calcium triggers highly efﬁcient
fusion of all three types of vesicles from their docked fusion-
restricted states given MUN domain-containing co-factors are
present.
An important realization concerns the inﬂuence of the MUN
domain proteins CAPS and Munc13 on calcium-triggered fusion
of the three native secretory vesicle types (Fig. 4). Our data on
vesicle protein composition (Supplementary Fig. 1) and that of
others17 indicate the variable presence of vesicle associated CAPS
—yet, its regulatory role has been broadly debated for dense-core
vesicles30, insulin vesicles31, and synaptic vesicles32. Considering
the evidence for at least partial functional overlap of CAPS and
Munc13, a clear generic effect of the MUN domain on fusion
probability and kinetics has been demonstrated in this work. The
characteristic delay observed in the fusion kinetics in the absence
of CAPS or Munc13 might indicate their role in catalyzing a
fusion competent conformation of a pre-fusion SNARE complex
before the arrival of Ca2+. Although Ca2+ stimulation is still
possible without these proteins, it happens with much lower
efﬁciency and with slower kinetics. It is important to note that we
previously found that the MUN domain alone only partially
rescues the impaired fusion kinetics and that for a full recovery of
the reaction the C1C2MUN fragment as well as phosphatidyli-
nositol-4,5-biphosphate in the target membrane were required3.
It is possible that the additional membrane binding domains
increase the efﬁciency of the MUN domain. However, one can
also speculate that the Munc13/CAPS-mediated priming of
secretory vesicles involves actions on the fusion proteins and the
lipid bilayer. The kinetic enhancements that we observe for
synaptic vesicles and CAPS-1/2 knockdown dense-core vesicles
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Fig. 5 Secretory vesicle kinetics have a vast range of fusion rates that
depend on vesicle size. a Cumulative distribution functions of the delay
times of fusion from the time of calcium arrival (ΔtCa2+) for the three
secretory vesicle types. Fusion of vesicles is triggered from a docked state
in the presence of syntaxin-1a:dSNAP-25, Munc18, complexin-1, and the
C1C2MUN domain of Munc13. Summary statistics for each condition are
shown in Supplementary Table 2. b Rate constants of dense-core vesicles
puriﬁed from PC12 cell lines depleted of endogenous synaptotagmins and
overexpressing single isoforms of synaptotagmin-1, -7, or -9. Vesicles were
docked in the presence of syntaxin-1a:dSNAP-25, Munc18, and complexin-1
and triggered to fuse with 100 µM calcium. Cumulative distribution
functions for synaptotagmin knock-ins are shown in Supplementary Fig. 6.
c Docking of all three secretory vesicles is inhibited by a soluble target
membrane Q-SNARE complex (syntaxin-1a(191–253):SNAP-25) in the
presence of Munc18 and complexin-1 and in the absence of calcium. d The
rate constant of fusion of all three secretory vesicle types in the absence or
presence of 0.5 µM syntaxin-1a(191–253):SNAP-25 is unchanged for
calcium-triggered fusion with planar-supported membranes containing
syntaxin-1a:dSNAP-25 in the presence of Munc18, complexin-1, and the
C1C2MUN domain of Munc13. e Vesicle diameter distributions of puriﬁed
secretory vesicles as measured by cryo-electron microscopy. Example
images are shown on top with scale bars being 100 nm. f Fitted fusion
rate constants (k (s−1)) from a plotted as a function of the mean curvature
(1/R), calculated from e. The ﬁtted black line assumes that the activation
energy depends linearly on the curvature of the fusing vesicles24. g To-
scale model showing the size differences of synaptic vesicles (green),
dense-core vesicles (red), and insulin vesicles (blue) docked to a planar
target membrane. Error bars represent standard errors of the mean
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been observed in a fully reconstituted model membrane fusion
assay33, but the response of fusion to calcium was less robust than
observed here with puriﬁed native secretory vesicles.
In this study, the puriﬁed recombinant fragment of
Munc13 serves as a valuable tool to establish equal degrees of
vesicle priming between the three secretory vesicle types. Addi-
tion of C1C2MUN allowed us to detect intrinsic differences in
fusion between the individual secretory vesicle types. Thus,
synaptic vesicles fused rapidly with a time constant of 0.23 s,
whereas dense-core vesicles were ~10-fold slower (3.3 s) and
insulin vesicles ~30-fold slower (9.1 s). Interestingly, our results
correlate with physiological differences between neurons, chro-
mafﬁn cells, and beta cells where regulated exocytosis of synaptic
vesicles and endocrine granules proceeds over quite different
timescales, indicating that even the ﬁnal step in the fusion path
preserves this large kinetic range34–38. The time constant of
230 ms for synaptic vesicles, although many orders of magnitude
faster than time constants measured in bulk reconstituted fusion
assays, is still slower than physiological rates of exocytosis in
neurons. One contributing factor for this difference is the rela-
tively slow delivery of calcium in our assay. The perfusion
delivery speed of the calcium-containing buffer is certainly much
slower than the localized rapid rise of calcium concentration via
calcium channels near fusion sites in synapses. The calcium
perfusion speed in our ﬂow through cell is therefore likely a rate
limiting step in our current assay. This inﬂuences the rate of
synaptic vesicle fusion the most because the ΔtCa is on the same
time scale as the measured rate constant for fusion (Supple-
mentary Table 2), indicating that synaptic vesicle fusion would
likely be still faster in our TIRF-based single-vesicle planar
membrane fusion assay system if calcium delivery was instanta-
neous. Despite this caveat, the relative difference of fusion rates of
the three native vesicle systems in an identical experimental
format is signiﬁcant and important.
The underlying cause for the intrinsic rate difference between
the three secretory vesicle types is unknown. The differential
requirement for the Munc13 construct, due to the presence of
different levels of endogenous CAPS between the vesicle types
could indicate differences in the protein machineries between the
vesicles. Alternatively, other unknown proteins that may be
associated with synaptic vesicles may enhance their fusion rate.
For example, secretory vesicles of different sources harbor dif-
ferent isoforms of synaptotagmin, such as synaptotagmin-1, -7,
and -9 on synaptic vesicles18, synaptotagmin-1 and -9 on dense-
core vesicles, and synaptotagmin-7 and -9 on insulin vesicles.
However, measuring the kinetics of fusion from calcium arrival
for dense-core vesicles with single knock-ins of each synapto-
tagmin isoform revealed different synaptotagmin isoforms are not
the underlying cause of the kinetic differences of different puriﬁed
secretory vesicles (Fig. 5b). The vesicle SNARE protein, VAMP-2,
is known to be one of the most abundant membrane proteins in
synaptic vesicles17. Titrations of soluble plasma membrane
SNAREs to reduce the effective VAMP density on the secretory
vesicles did not affect the rates of fusion from the time of calcium
arrival for either type of secretory vesicle (Fig. 5d). This rules out
that differences in VAMP density are the driving factor behind
the fast rate constant of synaptic vesicles compared to dense-core
and insulin vesicles.
Membrane composition is also well documented to affect
SNARE-mediated membrane fusion15,18,23,39–43, and differences
in lipid species between the secretory vesicle types could also have
a role in observed extents and rates of fusion. One obvious dif-
ference between the secretory vesicle types is their size (Fig. 5e).
Previously, experimental work has demonstrated membrane
curvature to heavily inﬂuence SNARE-mediated fusion in fully
reconstituted systems23,43. Although there are likely many
contributing factors for the observed kinetic differences, the
theoretical predicted dependence of fusion on membrane curva-
ture25 seems to be the dominant factor that distinguishes the
fusion rates of these three different types of secretory vesicles (Fig.
5f, g).
Methods
Materials. The following materials were purchased and used without further
puriﬁcation: porcine brain L-α-phosphatidylcholine (bPC), porcine brain L-α-
phosphatidylethanolamine (bPE), porcine brain L-α-phosphatidylserine (bPS), and
L-α-phosphatidylinositol (liver, bovine) (PI), and porcine brain phosphatidylino-
sitol-4,5-bisphosphate (bPIP2) were from Avanti Polar Lipids; DMPE-PEG2000-
triethoxysilan (DPS) was custom-synthesized by Shearwater Polymers (Huntsville,
AL); cholesterol, sodium cholate, EDTA, calcium, Opti-Prep Density Gradient
Medium, sucrose, MOPS, glutamic acid potassium salt monohydrate, potassium
acetate, adenosine 5′-triphosphate (ATP) magnesium (Mg2+) salt and glycerol
were from Sigma; CHAPS and DPC were from Anatrace; HEPES was from
Research Products International; chloroform, ethanol, Contrad detergent, all
inorganic acids and bases, and hydrogen peroxide were from Fisher Scientiﬁc.
Water was puriﬁed ﬁrst with deionizing and organic-free 3 ﬁlters (Virginia Water
Systems) and then with a NANOpure system from Barnstead to achieve a resis-
tivity of 18.2 MΩ cm−1.
Antibodies for synaptotagmin-1 (mouse monoclonal, catalog number 105 011),
synaptotagmin-7 (rabbit polyclonal, catalog number 105 173), and synaptobrevin-
2/VAMP-2 (mouse monoclonal, catalog number 104 211) were from
Synaptic Systems. The calnexin antibody (rabbit polyclonal, catalog number ADI-
SPA-860-D) was from Enzo Life Sciences, the secretogranin II antibody (mouse
monoclonal, catalog number 13441-RP01) was from Biodesign International, the
GFP antibody (mouse monoclonal, catalog number sc-9996) was from Santa Cruz,
and the succinate ubiquinone oxidoreductase antibody (mouse monoclonal) was
from Molecular Probes. All antibodies were used at dilutions of 1:1000.
Dense-core vesicle puriﬁcation from PC12 cells. Dense-core vesicle puriﬁcation
was described previously3. Pheochromocytoma 12 (PC12) cells (a gift from T.
Martin described in ref. 30) transfected with NPY-mRuby (~20 10-cm plates) were
scraped into PBS. Cells were pelleted by centrifugation and then suspended and
washed in homogenization medium (0.26 M sucrose, 5 mM MOPS, 0.2 mM
EDTA) by pelleting and re-suspending. Following re-suspension in 3 ml of med-
ium containing protease inhibitor (Roche Diagnostics), the cells were cracked open
using a ball bearing homogenizer with a 0.2507-inch bore and 0.2496-inch dia-
meter ball. The homogenate was spun at 1500 × g for 10 min at 4 °C in ﬁxed-angle
micro-centrifuge to pellet nuclei and larger debris. The post-nuclear supernatant
was collected and spun at 8000 × g for 15 min at 4 °C to pellet mitochondria. The
post-mitochondrial supernatant was then collected, adjusted to 5 mM EDTA, and
incubated 10 min on ice. A working solution of 50% Optiprep (iodixanol) (5 vol.
60% Optiprep: 1 vol. 0.26M sucrose, 30 mM MOPS, 1 mM EDTA) and homo-
genization medium were mixed to prepare solutions for discontinuous gradients in
Beckman SW55 tubes: 0.5 ml of 30% iodixanol on the bottom and 3.8 ml of 14.5%
iodixanol, above which 1.2 ml EDTA-adjusted supernatant was layered. Samples
were spun at 190,000 × g for 5 h. A clear white band at the interface between the
30% iodixanol and the 14.5% iodixanol was collected as the dense-core vesicle
sample (fraction 9 of western blot shown in Supplementary Fig. 1). The dense-core
vesicle sample was then extensively dialyzed in a cassette with 10,000 kDa mole-
cular weight cutoff (24–48 h, 3 × 5 l) into the fusion assay buffer (120 mM potas-
sium glutamate, 20 mM potassium acetate, 20 mM HEPES, pH 7.4). Western blots
of the fractionation were performed by taking 0.5 ml fractions from the top of the
density gradient. These fractions were pelleted by high speed centrifugation and the
pellets were re-suspended in 100 μl of SDS running buffer. SDS-PAGE was run and
samples were transferred to nitrocellulose membranes and blotted for secreto-
granin II (dense-core vesicle marker), synaptotagmin-1 (dense-core vesicle calcium
sensor), synaptobrevin-2/VAMP-2 (dense-core vesicle SNARE protein), calnexin
(endoplasmic reticulum marker), and succinate ubiquinone (mitochondrial
marker).
Insulin vesicle puriﬁcation from INS1 cells. Insulin vesicles were puriﬁed from
INS1 cells stably expressing human proinsulin-C-peptide-GFP were a gift from
P. Arvan and described in ref. 16. The puriﬁcation protocol was exactly as described
for dense-core vesicles above. Fraction 9 (14.5%/30% iodixanol interface), which
was harvested for our experiments, is highly enriched in insulin vesicles that are
either mostly or fully mature. Less dense organelles that minimally sediment in
14.5% iodixanol and are prominent in Fraction 3 include condensing vacuoles/
earliest immature granules and vesicles derived from ER and Golgi/TGN where
proinsulin-GFP is much more enriched relative to C-peptide-GFP, as well as
synaptic-like microvesicles and endosomes. Western blots of fractions generated
during puriﬁcation were performed as for dense-core vesicles except that anti-GFP
was used to track insulin vesicles. Similar to those of dense-core vesicles, western
blots were performed for GFP (insulin vesicle marker), synaptotagmin-7 (insulin
vesicle calcium sensor), synaptobrevin-2/VAMP-2 (insulin vesicle SNARE protein),
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calnexin (endoplasmic reticulum marker), and succinate ubiquinone oxidor-
eductase (mitochondrial marker).
Synaptic vesicle puriﬁcation. Synaptic vesicle puriﬁcation from rat brain was as
previously described17. The animals were kept following ethical guidelines
approved by the Ofﬁce of Veterinary Affairs and Consumer Protection of the city
of Göttingen Germany (permit number 32.22/Vo). Rat brains were homogenized in
buffer (320 mM sucrose, 4 mM HEPES-KOH, pH 7.4) in a glass-Teﬂon homo-
genizer. The homogenate was centrifuged at 1000 × g for 10 min. The resulting
supernatant was again centrifuged at 15,000 × g for 15 min. Synaptosomes were
osmotically lysed with ice-cold water and homogenized with three strokes at
2000 rpm in a homogenizer. The lysate was centrifuged at 25,000 × g for 20 min to
obtain LS1 fraction. LS1 was further centrifuged at 200,000 × g for 2 h. The
resulting LP2 fraction was suspended in 40 mM sucrose and layered on top of a
continuous sucrose gradient (from 0.05 to 0.8 M sucrose) and centrifuged at
65,000 × g for 4 h. Synaptic vesicles were collected at the interface of 0.4–0.6 M
sucrose and further puriﬁed on a size-exclusion chromatography column (con-
trolled pore glass beads).
Bulk secretory vesicle acridine orange loading assay. Secretory vesicles were
placed in a cuvette in the presence of 0.5 µM acridine orange and 1 µM valino-
mycin at room temperature. 1 mM ATP-Mg2+ was added to induce quenching of
acridine orange due to its concentration in the secretory vesicle interior20. Addition
of 1 µM CCCP was used to disrupt the proton gradient causing the acridine orange
ﬂuorescent signal to increase as the dye leaves the interior of the vesicle. Acid-
iﬁcation of secretory vesicles was inhibited by the presence of 0.5 µM baﬁlomycin.
Acridine orange loading of vesicles for TIRF microscopy. Secretory vesicles at
high concentration in a volume of 300 µL were incubated in the presence of 0.1 µM
acridine orange, 1 µM valinomycin, and 1 mM ATP-Mg2+ at room temperature for
10 min. The vesicles were then pelleted in a micro-centrifuge at 12,000 rpm for
5 min. The secretory vesicle pellet was suspended in buffer-containing valinomycin
and ATP-Mg2+ and then stored on ice. Immediately prior to imaging, vesicles were
diluted into normal assay buffer and imaged.
SNARE protein and complexin puriﬁcation. Syntaxin-1a (constructs of residues
183–288 and 1–288), SNAP-25, synaptobrevin-2 (soluble construct residues 1–96),
and complexin-1 from Rattus norvegicus were expressed in Escherichia coli strain
BL21(DE3) cells (New England Biolabs, Ipswich, MA) under the control of the T7
promoter in the pET28a expression vector and puriﬁed as described previously19.
Brieﬂy, proteins were puriﬁed using Ni-NTA afﬁnity chromatography. After
removal of N-terminal His tags by thrombin cleavage, the proteins were puriﬁed by
ion-exchange or size-exclusion chromatography when necessary. SNAP-25 was
quadruply dodecylated through disulﬁde bonding of dodecyl methanethiosulfonate
(Toronto Research Company, Toronto, Ontario) to its four native cysteines19.
Munc13 and Munc18 puriﬁcation. A protein construct containing the C1, C2B,
and MUN homology domains of R. norvegivus Munc13–1 (C1C2BMUN, residues:
529-1407, EF, 1453–1531) was expressed in E. coli using either the pET28a plasmid
originally described in ref. 3 or a variant of it, in which the thrombin cleavage site
following an N-terminal his6 tag was replaced with a TEV protease cleavage site.
The puriﬁcation protocols for both constructs were essentially the same except for
the cleavage reagents. The new plasmid was made by amplifying the original
plasmid with Phusion polymerase (New England Biolabs) and primers with
sequence CATCACAGCAGCGGCGAAAACCTGTATTTTCAGGGCATCACCT
CGGCCTTG and GCCGCTGCTGTGATGATGATGATGATGGCTGCTGCC,
followed by digestion with DpnI and transformation into NEB5alpha cells, using
reaction conditions recommended by the manufacturer. Replacement of the
thrombin cleavage site with a TEV protease cleavage site was conﬁrmed by Sanger
nucleotide sequencing (Genewiz, South Plainﬁeld, NJ). To produce C1C2BMUN,
the modiﬁed plasmid was transformed into Rosetta2(DE3) cells (Novagen, Bur-
lington, MA). A saturated overnight culture in LB+ 50 µg ml−1 kanamycin was
used to inoculate larger cultures (total of 4 l LB-kanamycin) at 37 °C. When these
cultures reached an OD600 of ~0.9, the temperature in the incubator was reduced to
18 °C, IPTG (isopropyl-β-D-thiogalactopyranoside) was added to a ﬁnal con-
centration of 1 mM, and growth was continued overnight. Cells were harvested, re-
suspended in 50 ml of NaHEPES pH 7.4, 500 mM NaCl, 20 mM imidazole-HCl pH
8, 10% (v/v) glycerol, 1 mM PMSF, 460 ng ml−1 leupeptin, 3.5 µg ml−1 pepstatin,
24 µg ml−1 AEBSF, frozen dropwise in liquid N2, and stored at −80 °C. Cells were
later thawed and lysed by four passes at 18,000 psi in a Microﬂuidizer M-110L
(Microﬂuidics). Lysate was clariﬁed by centrifugation (40 min at 138,000 × g
(42,000 rpm) in a Beckman 45 Ti rotor at 4 °C) and incubated with 10 ml Ni-NTA
resin (Qiagen) for 2 h at 4 °C with nutation. The resin was washed with 250 ml of
20 mM NaHEPES pH 7.4, 500 mM NaCl, 20 mM imidazole pH 8, and bound
protein was eluted with 20 mM NaHEPES pH 7.4, 100 mM NaCl, 300 mM
imidazole-HCl pH 8. EDTA (0.1 mM ﬁnal), DTT (1 mM ﬁnal), and TEV protease
(1:10 molar ratio) were added and the cleavage reaction was dialyzed against 2 l of
20 mM NaHEPES pH 7.4, 100 mM NaCl, 0.1 mM EDTA, 1 mM DTT at 4 °C
overnight, with one buffer change. Cleavage was conﬁrmed by SDS-PAGE and
Coomassie Brilliant Blue staining. Cleaved C1C2BMUN was subjected to anion
exchange chromatography (MonoQ 10/100 GL; GE Healthcare), then size-
exclusion chromatography (HiLoad 16/60 Superdex 200 prep grade; GE Health-
care) in 20 mM NaHEPES pH 7.4, 150 mM KCl, 1 mM DTT, 10% glycerol. Ali-
quots were frozen in liquid N2 and stored at −80 °C.
Munc18 (R. norvegicus munc18-1) was made essentially as described by Hu
et al.44, except that no detergent was used. Importantly, Munc18 was puriﬁed in the
presence of 10% glycerol in all buffers and in the ﬁnal puriﬁcation step by ion-
exchange chromotography (MonoQ). The inclusion of 10% glycerol improved the
stability and purity of the protein.
Planar-supported bilayers with plasma membrane SNAREs. Planar-supported
bilayers with reconstituted plasma membrane SNAREs were prepared by the
Langmuir–Blodgett/vesicle fusion technique as described in previous studies45–47.
Quartz slides were cleaned by dipping in 3:1 sulfuric acid:hydrogen peroxide for
15 min using a Teﬂon holder. Slides were then rinsed in milli-Q water. The ﬁrst
leaﬂet of the bilayer was prepared by Langmuir–Blodgett transfer onto the quartz
slide using a Nima 611 Langmuir–Blodgett trough (Nima, Conventry, UK) by
applying the lipid mixture of 70:30:3 bPC:Chol:DPS from a chloroform solution.
Solvent was allowed to evaporate for 10 min, the monolayer was compressed at a
rate of 10 cm2min−1 to reach a surface pressure of 32 mNm−1. After equilibration
for 5 min, a clean quartz slide was rapidly (200 mmmin−1) dipped into the trough
and slowly (5 mmmin−1) withdrawn, whereas a computer maintained a constant
surface pressure and monitored the transfer of lipids with head groups down onto
the hydrophilic substrate.
Plasma membrane SNARE-containing proteoliposomes with a lipid
composition of bPC:bPE:bPS:Chol:PI:PI(4,5)P2 (25:25:15:30:4:1) were prepared by
mixing the lipids and evaporating the organic solvents under a stream of N2 gas
followed by vacuum desiccation for at least 1 h. The dried lipid ﬁlms were dissolved
in 25 mM sodium cholate in a buffer (20 mM HEPES, 150 mM KCl, pH 7.4)
followed by the addition of an appropriate volume of synatxin-1a and SNAP-25 in
their respective detergents to reach a ﬁnal lipid/protein ratio of 3000 for each
protein. After 1 h of equilibration at room temperature, the mixture was diluted
below the critical micellar concentration by the addition of more buffer to the
desired ﬁnal volume. The sample was then dialyzed overnight against 1 l of buffer,
with one buffer change after ~4 h with Biobeads included in the dialysis buffer. To
complete formation of the SNARE-containing supported bilayers, proteoliposomes
were incubated with the Langmuir–Blodgett monolayer with the proteoliposome
lipids forming the outer leaﬂet of the planar-supported membrane and most
SNAREs oriented with their cytoplasmic domains away from the substrate and
facing the bulk aqueous region45–48. A concentration of ~77 μM total lipid in
1.2 ml total volume was used. Proteoliposomes were incubated for 1 h and excess
proteoliposomes were removed by perfusion with 5 ml of buffer (120 mM
potassium glutamate, 20 mM potassium acetate (20 mM potassium sulfate was
used in buffers with acridine orange labeled vesicles), 20 mM HEPES, 100 μM
EDTA, and pH 7.4.
Total internal reﬂection ﬂuorescence microscopy. Experiments examining
single-vesicle docking and fusion events were performed on a Zeiss Axiovert 35
ﬂuorescence microscope (Carl Zeiss), with a ×63 water immersion objective (Zeiss,
numerical aperture, 0.95) and a prism-based TIRF illumination. The light source
was an OBIS 532 LS laser or an OBIS 488 LS laser from Coherent Inc. Fluorescence
was observed through a 610 nm band pass ﬁlter (D610/60, Chroma) by an electron
multiplying charge coupled device (CCD) (DU-860E, Andor Technology). The
electron multiplying CCD (EMCCD) was cooled to −70 °C, and the gain was set at
200. The prism-quartz interface was lubricated with glycerol to allow easy trans-
location of the sample cell on the microscope stage. The beam was totally internally
reﬂected at an angle of 72° from the surface normal, resulting in an evanescent
wave that decays exponentially with a characteristic penetration depth of ~100 nm.
An elliptical area of 250 μm× 65 μm was illuminated. The laser intensity, shutter,
and camera were controlled by a homemade program written in LabVIEW
(National Instruments).
Experiments triggering secretory vesicle fusion with calcium were performed on
a Zeiss Axiovert 200 ﬂuorescence microscope (Carl Zeiss), with objective and TIRF
setups as described above. The light source was a 488 or 514 nm beamline of an
argon ion laser (Innova 90C, Coherent), controlled through an acousto-optic
modulator (Isomet), and a diode laser (Cube 640, Coherent) emitting light at
640 nm. The characteristic penetration depths were between 90 and 130 nm. An
OptoSplit (Andor Technology) was used to separate two ﬂuorescence spectral
bands. Fluorescence signals were recorded by an EMCCD (iXon DV887ESC-BV,
Andor Technology). The EMCCD camera was cooled to −70 °C, and the electron
gain was set at 200.
Single-vesicle planar-supported membrane assay. Single-vesicle planar-sup-
ported membrane docking and fusion has been previously described3,45. Plasma
membrane SNARE proteins-containing planar-supported bilayers were washed
with buffer (120 mM potassium glutamate, 20 mM potassium sulfate, 20 mM
HEPES, pH 7.4) containing 100 μM EDTA. Secretory vesicles were diluted into
2 ml of buffer and injected into the microscope ﬂow chamber containing the
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planar-supported membrane. The ﬂuorescence of the secretory vesicles was
recorded with a 532 nm laser for NPY-mRuby and C-peptide-GFP, and a 488 nm
laser for acridine orange. After injection, the microscope was focused within 30s
before images were taken at 200 ms exposure times for dense-core and insulin
vesicles, and 40 ms exposure times for synaptic vesicles. All experiments were
performed at room temperature.
Single-vesicle fusion data were analyzed using a homemade program written
in LabVIEW (National Instruments). Stacks of images were ﬁltered by a moving
average ﬁlter. The maximum intensity for each pixel over the whole stack was
projected on a single image. Vesicles were located in this image by a single-
particle detection algorithm described previously49. The central pixel and mean
ﬂuorescence intensities of a 5-pixel by 5-pixel area around each identiﬁed center
of mass were plotted as a function of time for all particles in the image series.
The exact time points of docking and fusion were determined from the central
pixel similar to previous work45. Numbers of docking and fusion events were
counted for each membrane. The fusion probability was determined by the
number of vesicles that underwent fusion compared with the total number of
observed vesicles. Docking was normalized for each secretory vesicle preparation
to the number of vesicles that docked in the condition of a bilayer-containing
syntaxin-1a (183–288) and dSNAP-25 in the presence of 100 μM EDTA.
Calcium-triggered single-vesicle fusion assay. Planar-supported bilayers-con-
taining syntaxin-1a:1-288dSNAP-25 (bulk phase-facing leaﬂet lipid composition of
25:25:15:30:4:1 bPC:bPE:bPS:Chol:PI:bPIP2) were incubated with 0.5 μM Munc18
and 2 μM complexin-1. Secretory vesicles were then injected while keeping the
concentrations of Munc18 and complexin-1 constant, with or without the presence
of 0.2 μM C1C2MUN from Munc13 as indicated in the text. Secretory vesicle
docking was allowed to occur for ~20 min before the chamber was placed on the
TIRF microscope and the microscope was focused on the planar-supported
membrane. Fluorescence from the sample was recorded while buffer containing
100 μM calcium was injected with a soluble Alexa647 dye in the buffer to monitor
the arrival of calcium at the observation site.
Cryo-electron microscopy of secretory vesicles. For each sample, 3.5 μl of
puriﬁed secretory vesicles were applied to C-ﬂat holey carbon grids (Electron
Microscopy Sciences). Using an FEI Vitrobot Mark IV the samples were blotted
for 4 s and plunge-frozen into liquid ethane. Images were recorded at a mag-
niﬁcation of ×29,000 under low electron-dose conditions (~20 e− Å−2) using a
4 k × 4 k CCD camera (Gatan, Pleasanton, CA) ﬁtted to a Tecnai F20 electron
microscope.
Data availability
Data supporting the ﬁndings of this manuscript are available from the corresponding
author upon reasonable request. A reporting summary for this article is available as a
Supplementary Information ﬁle. The source data underlying Figs. 3a, 4, 5a–d and
Supplementary Fig. 5 are provided as a Source Data ﬁle.
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